Concepedia

Lijun Xue

LX

Statistics

Publications

30

Citations

1.4K

H-Index

24

Active since

2003

Affiliations

Nanjing General Hospital of Nanjing Military Command(Current)

Nanjing University

City Of Hope National Medical Center

Nanjing Medical University

Southern Medical University

Lijun Xue is an author at Nanjing General Hospital of Nanjing Military Command specializing in medicine, oncology, and molecular biology.

ORCID

Publications per year

2003–2024

30

Publications

30

Wild-type p53 regulates human ribonucleotide reductase by protein-protein interaction with p53R2 as well as hRRM2 subunits.

Lijun Xue, Bingsen Zhou, Xiyong Liu et al. · PubMed · 2003 · 122 citations

, , +15

FAP‐Targeted Photodynamic Therapy Mediated by Ferritin Nanoparticles Elicits an Immune Response against Cancer Cells and Cancer Associated Fibroblasts

Shi-Yi Zhou, Zipeng Zhen, Amy V. Paschall et al. · Advanced Functional Materials · 2020 · 89 citations · Full text

, , +16

FOXM1 expression correlates with tumor invasion and a poor prognosis of colorectal cancer

Xiaoyuan Chu, Ziman Zhu, Longbang Chen et al. · Acta Histochemica · 2012 · 88 citations

, , +15

The human ribonucleotide reductase subunit hRRM2 complements p53R2 in response to UV-induced DNA repair in cells with mutant p53.

Bingsen Zhou, Xiyong Liu, Xueli Mo et al. · PubMed · 2003 · 85 citations

, , +15

Ribonucleotide Reductase Small Subunit M2B Prognoses Better Survival in Colorectal Cancer

Xiyong Liu, Lily Lai, Xiaochen Wang et al. · Cancer Research · 2011 · 70 citations · Full text

, , +17

1–5 of 30